Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-16

Clinical Trial Update: Defibrotide TMA Prophylaxis Pilot Trial [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating defibrotide for prophylaxis of thrombotic microangiopathy has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Defibrotide (defibrotide)

Snippet

Sponsor: University of California, San Francisco | Conditions: Thrombotic Microangiopathies | Phase 2 | Status: COMPLETED | Results posted: 2021-09-16